Clearside Biomedical (NASDAQ:CLSD) Price Target Lowered to $4.00 at Needham & Company LLC
Clearside Biomedical (NASDAQ:CLSD – Free Report) had its price target trimmed by Needham & Company LLC from $6.00 to $4.00 in a report released on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities research analysts also recently issued research reports about the stock. StockNews.com downgraded shares of Clearside Biomedical […]
Clearside Biomedical (NASDAQ:CLSD – Free Report) had its price target trimmed by Needham & Company LLC from $6.00 to $4.00 in a report released on Friday,Benzinga reports. The brokerage currently has a buy rating on the stock. Other equities research analysts also recently issued research reports about the stock. StockNews.com downgraded shares of Clearside Biomedical […]
